GlassScriptPhysician profile
Timothy Duffin
NPI 1144291527
$1,677.77
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $14.56 · 2021: $202 · 2022: $160 · 2023: $641 · 2024: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.15 |
| Travel and Lodging | $293.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $604.81 | 2023 | Aquabeam Robotic System |
| Astellas Pharma US INC | $251.39 | 2019-2024 | Xtandi |
| Neotract INC. | $137.03 | 2019 | |
| Endo Pharmaceuticals INC. | $103.87 | 2019 | |
| Bard Access Systems, INC. | $102.55 | 2019 | |
| Varian Medical Systems, INC. | $93.89 | 2021 | |
| Merck Sharp & Dohme LLC | $74.72 | 2019 | |
| Stryker Corporation | $68.61 | 2024 | Fluid Management System |
| Myovant Sciences INC. | $60.36 | 2021 | |
| Tolmar, INC. | $49.33 | 2024 | |
| Boston Scientific Corporation | $36.33 | 2023 | Rezum Generator |
| Abbvie INC. | $27.00 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $21.55 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.43 | 2021 | |
| Medtronic USA, INC. | $14.56 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Duffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.